🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a Phase II, single arm study looking at the rate of major clinical ...
Status
Recruiting
Location
University of Iowa Hospitals & Clinics
Start Date
2023-03-24
Trial ID
NCT05239546
Treatments Being Tested
TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 ...
Status
Active Not Recruiting
Location
University of Hawaii
Start Date
2019-12-19
Trial ID
NCT03680508
Treatments Being Tested
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
This study will monitor the safety of novel immunotherapy combinations in p...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05565378
Treatments Being Tested
This phase II trial tests how well niraparib and dostarlimab work in treati...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-10-17
Trial ID
NCT05870761
Treatments Being Tested
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
The goal of this study is to assess the safety and effectiveness of Dostarl...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-03-21
Trial ID
NCT06256588
Treatments Being Tested
To learn if chemotherapy given in combination with radiation therapy, follo...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-17
Trial ID
NCT05819892
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested